Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,465 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01230671 | The Physical and Psychological Benefits of Yoga and Breast Cancer | completed | Phase 1 | 80 | Dr. Sarkis MeterissianOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT00049582 | Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00363090 |
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma |
| unknown |
| Phase 1 / Phase 2 |
| 84 |
| Toronto Sunnybrook Regional Cancer CentreOTHER |
| 1 |
| Sep 20, 2013 |
| clinicaltrials |
| NCT00002887 | Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer | unknown | Phase 1 | 30 | Ottawa Regional Cancer CentreOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00002873 | Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jul 19, 2013 | clinicaltrials |
| NCT00003378 | Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer | terminated | Phase 1 | 45 | Gynecologic Oncology GroupNETWORK | 2 | Jul 9, 2013 | clinicaltrials |
| NCT00529100 | Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00009698 | Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia | completed | Phase 1 | 1 | Children's Oncology GroupNETWORK | 6 | Jun 28, 2013 | clinicaltrials |
| NCT00098995 | Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | completed | Phase 1 | 22 | Peter MacCallum Cancer Centre, AustraliaOTHER | 2 | Jun 26, 2013 | clinicaltrials |
| NCT00023725 | Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00023738 | Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00909402 | A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas | completed | Phase 1 | 39 | Bristol-Myers SquibbINDUSTRY | 4 | Jun 21, 2013 | clinicaltrials |
| NCT01050621 | Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective | completed | Phase 1 / Phase 2 | 14 | Jewish General HospitalOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00993486 | Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor | completed | Phase 1 / Phase 2 | 19 | Kiadis PharmaINDUSTRY | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00908024 | Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors | terminated | Phase 1 / Phase 2 | 54 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 18, 2013 | clinicaltrials |
| NCT00003380 | Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | terminated | Phase 1 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00927875 | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer | completed | Phase 1 | 5 | Bristol-Myers SquibbINDUSTRY | 5 | Jun 3, 2013 | clinicaltrials |
| NCT00659568 | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | completed | Phase 1 | 28 | London Health Sciences CentreOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00005026 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | completed | Phase 1 | — | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00780169 | Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer | completed | Phase 1 | 16 | Ottawa Hospital Research InstituteOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT01076530 | Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 2 | May 3, 2013 | clinicaltrials |
| NCT00420485 | Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors | completed | Phase 1 | 120 | Novartis PharmaceuticalsINDUSTRY | 7 | Apr 19, 2013 | clinicaltrials |
| NCT00910754 | A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 33 | Janssen Research & Development, LLCINDUSTRY | 2 | Apr 12, 2013 | clinicaltrials |
| NCT01017939 | A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 34 | Janssen Research & Development, LLCINDUSTRY | 2 | Apr 12, 2013 | clinicaltrials |
| NCT00024284 | Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 1 | — | Bristol-Myers SquibbINDUSTRY | 2 | Apr 5, 2013 | clinicaltrials |
| NCT00003703 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Jewish General HospitalOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00666926 | Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms | completed | Phase 1 | 99 | Verastem, Inc.INDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT00272649 | Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer | completed | Phase 1 / Phase 2 | 22 | Argos TherapeuticsINDUSTRY | 2 | Mar 14, 2013 | clinicaltrials |
| NCT00087984 | RNA-Loaded Dendritic Cell Cancer Vaccine | completed | Phase 1 / Phase 2 | 26 | Argos TherapeuticsINDUSTRY | 2 | Feb 18, 2013 | clinicaltrials |
| NCT00106353 | Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors | completed | Phase 1 / Phase 2 | 71 | PfizerINDUSTRY | 7 | Feb 8, 2013 | clinicaltrials |
| NCT01269411 | RO4929097 in Treating Patients With Recurrent Invasive Gliomas | terminated | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT01384890 | Feasibility of VMAT and CBCT for Head and Neck Carcinomas | completed | Phase 1 | 20 | British Columbia Cancer AgencyOTHER | 1 | Feb 6, 2013 | clinicaltrials |
| NCT00003288 | Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 2 | Feb 5, 2013 | clinicaltrials |
| NCT00003370 | Irofulven in Treating Children With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 3 | Feb 5, 2013 | clinicaltrials |
| NCT00003765 | O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 3 | Feb 5, 2013 | clinicaltrials |
| NCT00002705 | Topotecan in Treating Children With Refractory Leukemia | completed | Phase 1 | 3 | National Cancer Institute (NCI)NIH | 4 | Feb 1, 2013 | clinicaltrials |
| NCT00002912 | Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia | completed | Phase 1 | 3 | National Cancer Institute (NCI)NIH | 3 | Feb 1, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00772876 | A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies | completed | Phase 1 | 39 | Piramal Enterprises LimitedINDUSTRY | 1 | Nov 22, 2012 | clinicaltrials |
| NCT00197522 | Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 | completed | Phase 1 | 5 | Hamilton Health Sciences CorporationOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT01697891 | A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers | unknown | Phase 1 / Phase 2 | 35 | McMaster UniversityOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT00350233 | MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors | completed | Phase 1 | 10 | InSightecINDUSTRY | 2 | Sep 17, 2012 | clinicaltrials |
| NCT00303199 | Study of ZIO-101 in Multiple Myeloma | completed | Phase 1 / Phase 2 | 35 | Alaunos TherapeuticsINDUSTRY | 2 | Jul 19, 2012 | clinicaltrials |
| NCT00004015 | Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery | completed | Phase 1 | 36 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Jul 18, 2012 | clinicaltrials |
| NCT00788333 | Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer | completed | Phase 1 / Phase 2 | 40 | Bristol-Myers SquibbINDUSTRY | 5 | Jul 13, 2012 | clinicaltrials |
| NCT00793897 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 21 | Bristol-Myers SquibbINDUSTRY | 3 | Jul 13, 2012 | clinicaltrials |
| NCT00076024 | AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 174 | PfizerINDUSTRY | 8 | Jun 26, 2012 | clinicaltrials |
| NCT00761696 | A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies | completed | Phase 1 | 94 | Infinity Pharmaceuticals, Inc.INDUSTRY | 2 | Jun 21, 2012 | clinicaltrials |
| NCT00448695 | MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer | completed | Phase 1 | 12 | University Health Network, TorontoOTHER | 1 | Jun 15, 2012 | clinicaltrials |
| NCT00556023 | A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer | completed | Phase 1 | 37 | AstraZenecaINDUSTRY | 2 | Jun 6, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials